Related Experiment Video
Updated: Aug 22, 2025
08:52
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
3.1K
Biomarkers for Osteoarthritis Diseases
Jacob A Braaten1, Mark T Banovetz1, Nicholas N DePhillipo2
1University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Life (Basel, Switzerland)
|November 11, 2022
Summary
Inflammatory biomarkers are crucial in osteoarthritis development and offer potential for early diagnosis. Further research is needed to standardize biomarker measurement for clinical use in osteoarthritis.
Area of Science:
- Biomarkers
- Osteoarthritis Pathogenesis
- Inflammation
Background:
- Growing evidence highlights the role of inflammatory biomarkers in osteoarthritis pathogenesis.
- There is significant interest in the prognostic value of select biomarkers for early osteoarthritis identification and treatment.
- Novel therapeutics targeting osteoarthritis inflammatory pathways are under clinical investigation.
Purpose of the Study:
- To review current literature on key biomarkers in osteoarthritis.
- To examine biomarkers in the context of osteoarthritis pathogenesis, clinical symptom development, and treatment.
- To summarize the potential of biomarkers for early osteoarthritis diagnosis and management.
Main Methods:
- Literature review of recent studies on osteoarthritis biomarkers.
- Analysis of biomarker roles in disease pathology and clinical symptomology.
- Evaluation of current treatment capabilities related to inflammatory pathways.
Main Results:
- Multiple studies have identified biomarkers indicating osteoarthritis pathology and clinical symptom development.
- Biomarkers show promise for signaling the existence of osteoarthritis.
- Ongoing research is exploring novel therapeutics targeting inflammatory pathways.
Conclusions:
- Biomarker-driven investigations offer a promising approach for early osteoarthritis diagnosis and treatment.
- Additional research is required to define the prognostic value and standardize measurements for clinical implementation.
- Understanding inflammatory biomarkers is key to advancing osteoarthritis management.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
142
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
142
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
235
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
235
01:11Genome-wide Association Studies-GWAS
14.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.0K